Injectable Kaempferol-loaded Fibrin Glue Regulates the Metabolic Balance and Inhibits Inflammation in Intervertebral Disc Degeneration

Overview

Journal Sci Rep

Specialty Science

Date 2023 Nov 16

PMID 37968507

Authors

Wenshuo Gao

Jianhang Bao

Yujun Zhang

Du He

Liangping Zhang

Jun Zhang

Hao Pan

Dong Wang

Affiliations

Soon will be listed here.

Abstract

To construct an injectable fibrin glue system loaded with kaempferol (FG@F) to improve the bioavailability of kaempferol and observe its efficacy in the treatment of intervertebral disc degeneration (IVDD). Kaempferol-loaded fibrin glue was first synthesized in advance. Subsequently, the materials were characterized by various experimental methods. Then, nucleus pulposus cells (NPCs) were stimulated with lipopolysaccharide (LPS) to establish a degenerative cell model, and the corresponding intervention treatment was conducted to observe the effect in vitro. Finally, the tail disc of rats was punctured to establish a model of IVDD, and the therapeutic effect of the material in vivo was observed after intervertebral disc injection. The FG@F system has good injectability, sustained release and biocompatibility. This treatment reduced the inflammatory response associated with IVDD and regulated matrix synthesis and degradation. Animal experimental results showed that the FG@F system can effectively improve needle puncture-induced IVDD in rats. The FG@F system has better efficacy than kaempferol or FG alone due to its slow release and mechanical properties. The drug delivery and biotherapy platform based on this functional system might also serve as an alternative therapy for IVDD.

Citing Articles

Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and Aging.

Mavrogonatou E, Kletsas D Metabolites. 2024; 14(3).

PMID: 38535306 PMC: 10971879. DOI: 10.3390/metabo14030146.

References

Ashinsky B, Smith H, Mauck R, Gullbrand S . Intervertebral disc degeneration and regeneration: a motion segment perspective. Eur Cell Mater. 2021; 41:370-380. PMC: 8607668. DOI: 10.22203/eCM.v041a24. View

Han B, Zhu K, Li F, Xiao Y, Feng J, Shi Z . A simple disc degeneration model induced by percutaneous needle puncture in the rat tail. Spine (Phila Pa 1976). 2008; 33(18):1925-34. DOI: 10.1097/BRS.0b013e31817c64a9. View

Desmoulin G, Pradhan V, Milner T . Mechanical Aspects of Intervertebral Disc Injury and Implications on Biomechanics. Spine (Phila Pa 1976). 2019; 45(8):E457-E464. DOI: 10.1097/BRS.0000000000003291. View

Vashist A, Vashist A, Gupta Y, Ahmad S . Recent advances in hydrogel based drug delivery systems for the human body. J Mater Chem B. 2020; 2(2):147-166. DOI: 10.1039/c3tb21016b. View

Roberts S, Evans H, Trivedi J, Menage J . Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am. 2006; 88 Suppl 2:10-4. DOI: 10.2106/JBJS.F.00019. View

Koopman J, Duraku L, de Jong T, De Vries R, Zuidam J, Hundepool C . A systematic review and meta-analysis on the use of fibrin glue in peripheral nerve repair: Can we just glue it?. J Plast Reconstr Aesthet Surg. 2022; 75(3):1018-1033. DOI: 10.1016/j.bjps.2022.01.007. View

Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T . Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine (Lond). 2012; 7(8):1253-71. DOI: 10.2217/nnm.12.87. View

Zhu J, Tang H, Zhang Z, Zhang Y, Qiu C, Zhang L . Kaempferol slows intervertebral disc degeneration by modifying LPS-induced osteogenesis/adipogenesis imbalance and inflammation response in BMSCs. Int Immunopharmacol. 2017; 43:236-242. DOI: 10.1016/j.intimp.2016.12.020. View

Ortiz A, Fideles S, Pomini K, Reis C, Bueno C, Pereira E . Effects of Therapy with Fibrin Glue combined with Mesenchymal Stem Cells (MSCs) on Bone Regeneration: A Systematic Review. Cells. 2021; 10(9). PMC: 8468169. DOI: 10.3390/cells10092323. View

10.

Kepler C, Ponnappan R, Tannoury C, Risbud M, Anderson D . The molecular basis of intervertebral disc degeneration. Spine J. 2013; 13(3):318-30. DOI: 10.1016/j.spinee.2012.12.003. View

11.

Park C, Woo K . Fibrin-Based Biomaterial Applications in Tissue Engineering and Regenerative Medicine. Adv Exp Med Biol. 2018; 1064:253-261. DOI: 10.1007/978-981-13-0445-3_16. View

12.

Tsingas M, Ottone O, Haseeb A, Barve R, Shapiro I, Lefebvre V . Sox9 deletion causes severe intervertebral disc degeneration characterized by apoptosis, matrix remodeling, and compartment-specific transcriptomic changes. Matrix Biol. 2020; 94:110-133. PMC: 7778523. DOI: 10.1016/j.matbio.2020.09.003. View

13.

Almqvist K, Wang L, Wang J, Baeten D, Cornelissen M, Verdonk R . Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks. Ann Rheum Dis. 2001; 60(8):781-90. PMC: 1753804. DOI: 10.1136/ard.60.8.781. View

14.

Buchaim D, Cassaro C, Shindo J, Della Coletta B, Pomini K, Rosso M . Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review. J Venom Anim Toxins Incl Trop Dis. 2019; 25:e20190038. PMC: 6894437. DOI: 10.1590/1678-9199-JVATITD-2019-0038. View

15.

Xing H, Zhang Z, Mao Q, Wang C, Zhou Y, Zhou X . Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration. J Nanobiotechnology. 2021; 19(1):264. PMC: 8419940. DOI: 10.1186/s12951-021-00991-5. View

16.

Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C . The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014; 73(6):968-74. DOI: 10.1136/annrheumdis-2013-204428. View

17.

Francisco V, Pino J, Gonzalez-Gay M, Lago F, Karppinen J, Tervonen O . A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol. 2021; 18(1):47-60. DOI: 10.1038/s41584-021-00713-z. View

18.

Bermudez-Lekerika P, Crump K, Tseranidou S, Nuesch A, Kanelis E, Alminnawi A . Immuno-Modulatory Effects of Intervertebral Disc Cells. Front Cell Dev Biol. 2022; 10:924692. PMC: 9277224. DOI: 10.3389/fcell.2022.924692. View

19.

Periferakis A, Periferakis K, Badarau I, Petran E, Popa D, Caruntu A . Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications. Int J Mol Sci. 2022; 23(23). PMC: 9740324. DOI: 10.3390/ijms232315054. View

20.

Le Maitre C, Pockert A, Buttle D, Freemont A, Hoyland J . Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 2007; 35(Pt 4):652-5. DOI: 10.1042/BST0350652. View